©The Author(s) 2021.
World J Diabetes. Sep 15, 2021; 12(9): 1426-1441
Published online Sep 15, 2021. doi: 10.4239/wjd.v12.i9.1426
Published online Sep 15, 2021. doi: 10.4239/wjd.v12.i9.1426
Table 1 List of the keywords used for literature search
| No. | |
| 1 | Dipeptidyl peptidase 4 inhibitor |
| 2 | DPP-4 inhibitor |
| 3 | Gliptins |
| 4 | ‘Autoimmune disease’ |
| 5 | [1] and [4] |
| 6 | [2] and [4] |
| 7 | [3] and [4] |
| 8 | [2] and [3] and [4] |
| 9 | Inflammatory bowel disease |
| 10 | [1] and [9] |
| 11 | Arthritis |
| 12 | Arthralgia |
| 13 | ‘Rheumatoid arthritis’ |
| 14 | [1] and [11] |
| 15 | [1] and [12] |
| 16 | [1] and [13] |
- Citation: Roy A, Sahoo J, Narayanan N, Merugu C, Kamalanathan S, Naik D. Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: Current evidence. World J Diabetes 2021; 12(9): 1426-1441
- URL: https://www.wjgnet.com/1948-9358/full/v12/i9/1426.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i9.1426